Cargando…

Onconase Restores Cytotoxicity in Dabrafenib-Resistant A375 Human Melanoma Cells and Affects Cell Migration, Invasion and Colony Formation Capability

Melanoma is a lethal tumor because of its severe metastatic potential, and serine/threonine-protein kinase B-raf inhibitors (BRAFi) are used in patients harboring BRAF-mutation. Unfortunately, BRAFi induce resistance. Therefore, we tested the activity of onconase (ONC), a cytotoxic RNase variant, ag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raineri, Alice, Fasoli, Sabrina, Campagnari, Rachele, Gotte, Giovanni, Menegazzi, Marta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928899/ https://www.ncbi.nlm.nih.gov/pubmed/31783660 http://dx.doi.org/10.3390/ijms20235980

Ejemplares similares

Upregulation of miR-34a-5p, miR-20a-3p and miR-29a-3p by Onconase in A375 Melanoma Cells Correlates with the Downregulation of Specific Onco-Proteins
por: De Tomi, Elisa, et al.
Publicado: (2022)

Role of the Ribonuclease ONCONASE in miRNA Biogenesis and tRNA Processing: Focus on Cancer and Viral Infections
por: Menegazzi, Marta, et al.
Publicado: (2022)

Salviolone from Salvia miltiorrhiza Roots Impairs Cell Cycle Progression, Colony Formation, and Metalloproteinase-2 Activity in A375 Melanoma Cells: Involvement of P21(Cip1/Waf1) Expression and STAT3 Phosphorylation
por: Zanrè, Valentina, et al.
Publicado: (2022)

RNase A Domain-Swapped Dimers Produced Through Different Methods: Structure–Catalytic Properties and Antitumor Activity
por: Montioli, Riccardo, et al.
Publicado: (2021)

microRNA-494 and ATF3 the targets of onconase(?)
por: Darzynkiewicz, Zbigniew
Publicado: (2016)

Phenotype characterization of human melanoma cells resistant to dabrafenib
por: Cordaro, Fabiola Gilda, et al.
Publicado: (2017)

Chlorotoxin-conjugated onconase as a potential anti-glioma drug
por: WANG, XIAOMIN, et al.
Publicado: (2015)

Hyperforin Elicits Cytostatic/Cytotoxic Activity in Human Melanoma Cell Lines, Inhibiting Pro-Survival NF-κB, STAT3, AP1 Transcription Factors and the Expression of Functional Proteins Involved in Mitochondrial and Cytosolic Metabolism
por: Cardile, Alessia, et al.
Publicado: (2023)

Onconase responsive genes in human mesothelioma cells: implications for an RNA damaging therapeutic agent
por: Altomare, Deborah A, et al.
Publicado: (2010)

Dabrafenib for treatment of BRAF-mutant melanoma
por: Kainthla, Radhika, et al.
Publicado: (2013)

3,5-Dicaffeoylquinic Acid Lowers 3T3-L1 Mitotic Clonal Expansion and Adipocyte Differentiation by Enhancing Heme Oxygenase-1 Expression
por: Raineri, Alice, et al.
Publicado: (2021)

Onconase Mediated NFKβ Down-Regulation in Malignant Pleural Mesothelioma
por: Goparaju, Chandra M., et al.
Publicado: (2011)

New withanolides from Physalis minima and their cytotoxicity against A375 human melanoma cells
por: Zhang, Meng, et al.
Publicado: (2020)

Combined Therapy with Dacarbazine and Hyperthermia Induces Cytotoxicity in A375 and MNT-1 Melanoma Cells
por: Salvador, Diana, et al.
Publicado: (2022)

Antioxidant and cytotoxic potentials of the methanolic extract of Teucrium persicum Boiss. in A-375 melanoma cells
por: Naeimi, Anahita, et al.
Publicado: (2022)

Dabrafenib and its potential for the treatment of metastatic melanoma
por: Menzies, Alexander M, et al.
Publicado: (2012)

Leukocyte Count Restoration Under Dabrafenib Treatment in a Melanoma Patient With Vemurafenib-Induced Leukopenia: Case Report
por: Orouji, Elias, et al.
Publicado: (2014)

Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma
por: Rossi, Ernesto, et al.
Publicado: (2019)

Primary Melanoma of the Lung Treated with Surgery, Dabrafenib and Trametinib
por: Landgraf, Layla G., et al.
Publicado: (2020)

Endoplasmic reticulum stress-induced autophagy determines the susceptibility of melanoma cells to dabrafenib
por: Ji, Chao, et al.
Publicado: (2016)

Dabrafenib–Panobinostat Salt: Improving the Dissolution Rate and Inhibition of BRAF Melanoma Cells
por: Rai, Sunil K., et al.
Publicado: (2023)

Activating transcription factor 3 is crucial for antitumor activity and to strengthen the antiviral properties of Onconase
por: Vert, Anna, et al.
Publicado: (2016)

Endoplasmic Reticulum Stress-Induced Autophagy Determines the Susceptibility of Melanoma Cells to Dabrafenib [Retraction]
Publicado: (2023)

Crystal structure of Onconase at 1.1 Å resolution – insights into substrate binding and collective motion
por: Holloway, Daniel E, et al.
Publicado: (2011)

Severe bilateral panuveitis during melanoma treatment by Dabrafenib and Trametinib
por: Draganova, Dafina, et al.
Publicado: (2015)

Dabrafenib in metastatic melanoma: a monocentric ‘real life’ experience
por: Cocorocchio, E, et al.
Publicado: (2016)

Consolidation electrochemotherapy with bleomycin in metastatic melanoma during treatment with dabrafenib
por: Valpione, Sara, et al.
Publicado: (2015)

Identification of Key miRNAs in the Treatment of Dabrafenib-Resistant Melanoma
por: Gao, Guangyu, et al.
Publicado: (2021)

Successful Dabrafenib Desensitization Protocols in a Patient with Metastatic Melanoma
por: Bumbacea, Roxana Silvia, et al.
Publicado: (2022)

Dabrafenib-Trametinib and Radiotherapy for Oligoprogressive BRAF Mutant Advanced Melanoma
por: Rossi, Ernesto, et al.
Publicado: (2023)

A Humanized Anti-CD22-Onconase Antibody-Drug Conjugate Mediates Highly Potent Destruction of Targeted Tumor Cells
por: Weber, Tobias, et al.
Publicado: (2015)

Effect of dabrafenib on melanoma cell lines harbouring the BRAF(V600D/R) mutations
por: Gentilcore, Giusy, et al.
Publicado: (2013)

The Selective Cytotoxicity of Quercus Brantii Lindl. Galls on A375 and SK-MEL-3 Human Malignant Melanoma Cell Lines
por: Yousefsani, Bahareh Sadat, et al.
Publicado: (2023)

β- and γ-Actins in the nucleus of human melanoma A375 cells
por: Migocka-Patrzałek, Marta, et al.
Publicado: (2015)

The Induction of Apoptosis in A375 Malignant Melanoma Cells by Sutherlandia frutescens
por: van der Walt, Nicola B., et al.
Publicado: (2016)

BRAF-Inhibitor-Induced Metabolic Alterations in A375 Melanoma Cells
por: Karki, Prashant, et al.
Publicado: (2021)

Dabrafenib: A New Therapy for Use in BRAF-Mutated Metastatic Melanoma
por: McGettigan, Suzanne
Publicado: (2014)

Human Melanoma Cells Differentially Express RNASEL/RNase-L and miR-146a-5p under Sex Hormonal Stimulation
por: Orlandi, Elisa, et al.
Publicado: (2022)

Role of Tumor-Infiltrating B Cells in Clinical Outcome of Patients with Melanoma Treated With Dabrafenib Plus Trametinib
por: Brase, Jan C., et al.
Publicado: (2021)

Triclosan induces ROS-dependent cell death and autophagy in A375 melanoma cells
por: Jin, Jing, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l27nrudr8tn9as3lmqnmkth24s